TTM
$1.37B
YoY change
-20.8%
5Y CAGR
-20.2%
Peak year (2019)
$5.89B
Cumulative net income
$44.72B
Net Income history chart for Biogen (BIIB) from 1985 to 2025
Latest: $1.29B
Net Income growth chart for Biogen (BIIB) from 1985 to 2025
Latest: -20.8%
Net Income history table for Biogen (BIIB) from 1985 to 2025
| 2025 | $1.29B | -20.8% | −$338.81M | ||
| 2024 | $1.63B | +40.6% | +$471.10M | ||
| 2023 | $1.16B | -61.9% | −$1.89B | ||
| 2022 | $3.05B | +95.8% | +$1.49B | ||
| 2021 | $1.56B | -61.1% | −$2.44B | ||
| 2020 | $4.00B | -32.1% | −$1.89B | ||
| 2019 | $5.89B | +32.9% | +$1.46B | ||
| 2018 | $4.43B | +74.5% | +$1.89B | ||
| 2017 | $2.54B | -31.4% | −$1.16B | ||
| 2016 | $3.70B | +4.4% | +$155.80M | ||
| 2015 | $3.55B | +20.9% | +$612.20M | ||
| 2014 | $2.93B | +57.6% | +$1.07B | ||
| 2013 | $1.86B | +34.9% | +$482.27M | ||
| 2012 | $1.38B | +11.8% | +$145.60M | ||
| 2011 | $1.23B | +22.8% | +$229.16M | ||
| 2010 | $1.01B | +3.6% | +$35.14M | ||
| 2009 | $970.13M | +23.9% | +$186.97M | ||
| 2008 | $783.17M | +22.7% | +$145.00M | ||
| 2007 | $638.17M | +193.4% | +$420.66M | ||
| 2006 | $217.51M | +35.3% | +$56.80M | ||
| 2005 | $160.71M | +540.6% | +$135.63M | ||
| 2004 | $25.09M | -102.9% | +$900.18M | ||
| 2003 | −$875.10M | -690.9% | −$1.02B | ||
| 2002 | $148.09M | -45.7% | −$124.59M | ||
| 2001 | $272.68M | -18.3% | −$60.89M | ||
| 2000 | $333.58M | +51.3% | +$113.13M | ||
| 1999 | $220.45M | +58.9% | +$81.75M | ||
| 1998 | $138.70M | +55.5% | +$49.53M | ||
| 1997 | $89.17M | +120.0% | +$48.64M | ||
| 1996 | $40.53M | +616.1% | +$34.87M | ||
| 1995 | $5.66M | -215.6% | +$10.56M | ||
| 1994 | −$4.90M | -115.1% | −$37.30M | ||
| 1993 | $32.40M | -15.4% | −$5.90M | ||
| 1992 | $38.30M | +431.9% | +$31.10M | ||
| 1991 | $7.20M | -6.5% | −$500.00K | ||
| 1990 | $7.70M | +140.6% | +$4.50M | ||
| 1989 | $3.20M | -366.7% | +$4.40M | ||
| 1988 | −$1.20M | -94.7% | +$21.40M | ||
| 1987 | −$22.60M | -19.9% | +$5.60M | ||
| 1986 | −$28.20M | +47.6% | −$9.10M | ||
| 1985 | −$19.10M | — | — |
- 2025$1.29B-20.8%
- 2024$1.63B+40.6%
- 2023$1.16B-61.9%
- 2022$3.05B+95.8%
- 2021$1.56B-61.1%
- 2020$4.00B-32.1%
- 2019$5.89B+32.9%
- 2018$4.43B+74.5%
- 2017$2.54B-31.4%
- 2016$3.70B+4.4%
- 2015$3.55B+20.9%
- 2014$2.93B+57.6%
- 2013$1.86B+34.9%
- 2012$1.38B+11.8%
- 2011$1.23B+22.8%
- 2010$1.01B+3.6%
- 2009$970.13M+23.9%
- 2008$783.17M+22.7%
- 2007$638.17M+193.4%
- 2006$217.51M+35.3%
- 2005$160.71M+540.6%
- 2004$25.09M-102.9%
- 2003−$875.10M-690.9%
- 2002$148.09M-45.7%
- 2001$272.68M-18.3%
- 2000$333.58M+51.3%
- 1999$220.45M+58.9%
- 1998$138.70M+55.5%
- 1997$89.17M+120.0%
- 1996$40.53M+616.1%
- 1995$5.66M-215.6%
- 1994−$4.90M-115.1%
- 1993$32.40M-15.4%
- 1992$38.30M+431.9%
- 1991$7.20M-6.5%
- 1990$7.70M+140.6%
- 1989$3.20M-366.7%
- 1988−$1.20M-94.7%
- 1987−$22.60M-19.9%
- 1986−$28.20M+47.6%
- 1985−$19.10M—
Net Income values are taken from Biogen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's current net income (TTM) is $1.37B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Biogen (BIIB) net income is $1.29B – declined 20.8% year-over-year.
Across 2020–2025 (5 years), Biogen net income produced a CAGR of -20.2% – with a net decline across the window.
Biogen net income plunged from $5.89B in 2019 to $1.29B in 2025, a 78.0% drawdown.
Across the available history, net income reached its high of $5.89B in 2019 and its low of −$875.10M in 2003.
Biogen Net Income by Year
Biogen Net Income 2025: $1.29B
Biogen posted net income of $1.29B in 2025, declined 20.8% below 2024.
Biogen Net Income 2024: $1.63B
In 2024, Biogen reported net income of $1.63B, surged 40.6% from 2023.
Biogen Net Income 2023: $1.16B
Biogen net income in 2023 was $1.16B, plunged 61.9% below 2022.
Biogen Net Income 2022: $3.05B
2022's net income for Biogen came in at $3.05B, surged 95.8% from 2021.
Biogen Net Income 2021: $1.56B
Biogen net income in 2021 was $1.56B.
See more financial history for Biogen (BIIB).
Sector peers by Net Income
Healthcare peers of Biogen (BIIB), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Biogen (BIIB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation